NTRK2 and cancer: Rearrangements involving the neurotrophic-tropomyosin receptor kinase (NTRK) gene family (<i>NTRK1, NTRK2</i>, and <i>NTRK3</i>) have been identified as drivers in a wide variety of human cancers.